Your First Choice in Complex Biologics Drug Development Video Your First Choice in Complex Biologics Drug Development The pharmaceutical has made massive investments in complex biologics, a drug class that includes oligonucleotide…Certara2021年6月1日
The Wizard of Oligos: There’s no place like having a successful drug development program! オンデマンド・ウェビナー The Wizard of Oligos: There’s no place like having a successful drug development program! Oligonucleotide therapies— nucleic acid polymers with the potential to treat or manage a wide range…Certara2021年4月30日
Certara (CERT) – Accelerating Medicines with Biosimulation Video Certara (CERT) – Accelerating Medicines with Biosimulation As seen on CNBC** Certara is the global leader in biosimulation, a powerful and proven…Certara2021年4月27日
Part 3: Oligonucleotide therapeutic development: Clinical pharmacology considerations On-Demand Webinar パート 3:Oligonucleotide therapeutic development: Clinical pharmacology considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021年4月21日
Part 2: Oligonucleotide therapeutic development: Pre-clinical and translational considerations On-Demand Webinar パート 2:Oligonucleotide therapeutic development: Pre-clinical and translational considerations In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021年4月21日
Part 1: What are oligonucleotide therapeutics, and how do they work? オンデマンド・ウェビナー パート1:What are oligonucleotide therapeutics, and how do they work? In the last few years, the pharmaceutical industry has invested in developing Complex Biologics including…Certara2021年4月21日
Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure On-Demand Webinar Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…Certara2021年4月1日
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence Publication Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence The extent of cross-protection provided by currently licensed bivalent and quadrivalent HPV vaccines versus direct…Certara2021年3月18日
Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors On-Demand Webinar Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors It is crucial for biotech developers to engage in early commercial market assessment to generate…Certara2021年3月5日
BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection Publication BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…Certara2021年2月9日